Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Sales | 109,363 | 78,416 | 74,331 | 50,915 | 50,687 |
| Cost of Goods | 17,718 | 12,042 | 13,178 | 9,208 | 10,797 |
| Gross Profit | 91,645 | 66,374 | 61,153 | 41,707 | 39,890 |
| Operating Expenses | 73,169 | 73,359 | 86,255 | 77,983 | 74,582 |
| Operating Income | 19,194 | -6,943 | -24,924 | -36,068 | -33,895 |
| Interest Expense | 3,455 | 3,482 | 3,498 | 3,513 | 3,436 |
| Other Income | 4,610 | 5,611 | 163,167 | 14,559 | 5,267 |
| Pre-tax Income | 20,349 | -4,814 | 134,745 | -25,022 | -32,064 |
| Income Tax | 638 | -964 | 3,168 | 174 | 323 |
| Net Income Continuous | 19,711 | -3,850 | 131,577 | -25,196 | -32,387 |
| Net Income | $19,711 | $-3,850 | $131,577 | $-25,196 | $-32,387 |
| EPS Basic Total Ops | 0.01 | 0.00 | 0.09 | -0.02 | -0.02 |
| EPS Basic Continuous Ops | 0.01 | 0.00 | 0.09 | -0.02 | -0.02 |
| EPS Diluted Total Ops | 0.01 | 0.00 | 0.08 | -0.02 | -0.02 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | 0.08 | -0.02 | -0.02 |
| EBITDA(a) | $22,627 | $-3,585 | $-21,079 | $-32,275 | $-30,287 |